FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Generics Montelukast Sodium Tablets Recall

Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (N…

Glenmark Generics Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Mar 13, 2013
Recall ID
D-182-2013
Check your lot numberHow we source this data

Summary

Glenmark Generics recalled Montelukast Sodium Tablets starting Feb 13, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-182-2013 on Mar 13, 2013. Reason: Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA). Status: Terminated.

Why it was recalled

Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).

Product description

Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430.

Lot numbers, UPCs & expiration codes

02122956, 02123226, 02123269, 02123480, 02123481, 02122933, 02122955, 02123062, 02123075, 02123085, 02123114, 02123115, 02123124, 02123125, 02123189, 02123199, 02123205, 02123219, 02123253, 02123270, 02123289, 02123295, 02123320, 02123333, 02123343, 02123349, 02123411, 02123421, 02123431, Exp 09/14 and 10/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-182-2013
Classification
Class III
Status
Terminated
Recall initiated
Feb 13, 2013
FDA report date
Mar 13, 2013
Quantity
591,972 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Generics Inc., USA

Original FDA data

Every field from FDA enforcement report D-182-2013, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
64338
Address
750 Corporate Dr
Code information
02122956, 02123226, 02123269, 02123480, 02123481, 02122933, 02122955, 02123062, 02123075, 02123085, 02123114, 02123115, 02123124, 02123125, 02123189, 02123199, 02123205, 02123219, 02123253, 02123270, 02123289, 02123295, 02123320, 02123333, 02123343, 02123349, 02123411, 02123421, 02123431, Exp 09/14 and 10/14
Postal code
07430-2009
Report date
Mar 13, 2013
Product type
Drugs
Recall number
D-182-2013
Classification
Class III
Recalling firm
Glenmark Generics Inc., USA
Product quantity
591,972 bottles
Termination date
Oct 9, 2014
Reason for recall
Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430.
Distribution pattern
Nationwide
Recall initiation date
Feb 13, 2013
Initial firm notification
Letter
Center classification date
Mar 5, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-182-2013, published Mar 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls